188 related articles for article (PubMed ID: 31965981)
41. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia-inducible factor (HIF)-3alpha is subject to extensive alternative splicing in human tissues and cancer cells and is regulated by HIF-1 but not HIF-2.
Pasanen A; Heikkilä M; Rautavuoma K; Hirsilä M; Kivirikko KI; Myllyharju J
Int J Biochem Cell Biol; 2010 Jul; 42(7):1189-200. PubMed ID: 20416395
[TBL] [Abstract][Full Text] [Related]
43. Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer.
Aversa R; Sorrentino A; Esposito R; Ambrosio MR; Amato A; Zambelli A; Ciccodicola A; D'Apice L; Costa V
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784191
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia alters splicing of the cancer associated Fas gene.
Peciuliene I; Vilys L; Jakubauskiene E; Zaliauskiene L; Kanopka A
Exp Cell Res; 2019 Jul; 380(1):29-35. PubMed ID: 31002816
[TBL] [Abstract][Full Text] [Related]
45. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q
Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580
[TBL] [Abstract][Full Text] [Related]
46. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
[TBL] [Abstract][Full Text] [Related]
47. Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression.
Canzoneri R; Rabassa ME; Gurruchaga A; Ferretti V; Palma S; Isla-Larrain M; Croce MV; Lacunza E; Abba MC
Oncol Rep; 2018 Aug; 40(2):909-915. PubMed ID: 29901166
[TBL] [Abstract][Full Text] [Related]
48. TARBP2 Suppresses Ubiquitin-Proteasomal Degradation of HIF-1α in Breast Cancer.
Li JN; Chen PS; Chiu CF; Lyu YJ; Lo C; Tsai LW; Wang MY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008634
[TBL] [Abstract][Full Text] [Related]
49. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
50. LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.
Yang J; Bennett BD; Luo S; Inoue K; Grimm SA; Schroth GP; Bushel PR; Kinyamu HK; Archer TK
Mol Cell Biol; 2015 Sep; 35(18):3225-43. PubMed ID: 26149387
[TBL] [Abstract][Full Text] [Related]
51. Hypoxia Alters the Response to Anti-EGFR Therapy by Regulating EGFR Expression and Downstream Signaling in a DNA Methylation-Specific and HIF-Dependent Manner.
Mamo M; Ye IC; DiGiacomo JW; Park JY; Downs B; Gilkes DM
Cancer Res; 2020 Nov; 80(22):4998-5010. PubMed ID: 33023947
[TBL] [Abstract][Full Text] [Related]
52. Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α.
Koslowski M; Luxemburger U; Türeci O; Sahin U
Oncogene; 2011 Feb; 30(7):876-82. PubMed ID: 21042279
[TBL] [Abstract][Full Text] [Related]
53. Hypoxia inducible factor-1α-mediated activation of survivin in cervical cancer cells.
Bai H; Ge S; Lu J; Qian G; Xu R
J Obstet Gynaecol Res; 2013 Feb; 39(2):555-63. PubMed ID: 22925504
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
[TBL] [Abstract][Full Text] [Related]
55. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
[TBL] [Abstract][Full Text] [Related]
56. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
Jarman EJ; Ward C; Turnbull AK; Martinez-Perez C; Meehan J; Xintaropoulou C; Sims AH; Langdon SP
Breast Cancer Res; 2019 Jan; 21(1):10. PubMed ID: 30670058
[TBL] [Abstract][Full Text] [Related]
57. Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer.
Bol GM; Raman V; van der Groep P; Vermeulen JF; Patel AH; van der Wall E; van Diest PJ
PLoS One; 2013; 8(5):e63548. PubMed ID: 23696831
[TBL] [Abstract][Full Text] [Related]
58. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site.
Wenger RH; Kvietikova I; Rolfs A; Camenisch G; Gassmann M
Eur J Biochem; 1998 May; 253(3):771-7. PubMed ID: 9654078
[TBL] [Abstract][Full Text] [Related]
59. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A
J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316
[TBL] [Abstract][Full Text] [Related]
60. Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2.
Hoffmann C; Mao X; Brown-Clay J; Moreau F; Al Absi A; Wurzer H; Sousa B; Schmitt F; Berchem G; Janji B; Thomas C
Sci Rep; 2018 Jul; 8(1):10191. PubMed ID: 29976963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
